肺纤维化-话题@MedSci

#肺纤维化#

12篇内容 | 3516人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2113354, encodeId=8f702113354ab, content=<a href='/topic/show?id=9c2d1031961f' target=_blank style='color:#2F92EE;'>#黄芪#</a>是一种很有前途的<a href='/topic/show?id=d7545560388' target=_blank style='color:#2F92EE;'>#抗纤维化#</a>药物，最好还要配合<a href='/topic/show?id=cf43105266ac' target=_blank style='color:#2F92EE;'>#活血#</a>的药物，或溶栓类药物、化痰类药物一起治疗，应该有一定的潜力，对<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>，<a href='/topic/show?id=246c82641b7' target=_blank style='color:#2F92EE;'>#肾纤维化#</a>，<a href='/topic/show?id=3ed881343fa' target=_blank style='color:#2F92EE;'>#肝纤维化#</a>等。, objectTitle=黄芪及其配方作为纤维化疾病的治疗选择, objectType=article, longId=758719, objectId=35e4e58719de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021926/1632649459662_5552845.jpg, objectUrl=/article/show_article.do?id=35e4e58719de, replyNumber=0, likeNumber=178, createdTime=2023-02-07, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=35e4e58719de, moduleTitle=黄芪及其配方作为纤维化疾病的治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35e4e58719de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2096684, encodeId=ffb42096684b0, content=<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>吡非尼酮尼达尼布, objectTitle=综述：特发性肺纤维化治疗药物治疗进展, objectType=article, longId=216060, objectId=d14f21606025, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20210819/432253f6fe8b4ccf8ed27604419d1b28.jpg, objectUrl=/article/show_article.do?id=d14f21606025, replyNumber=0, likeNumber=134, createdTime=2022-10-28, rootId=0, userName=ms6000000798514104, userId=18278401100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d14f21606025, moduleTitle=综述：特发性肺纤维化治疗药物治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d14f21606025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1204281, encodeId=75201204281f4, content=<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, objectTitle=Thorax：吸烟对特发性肺纤维化发展的影响, objectType=article, longId=218303, objectId=584521830347, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021109/1633745859432_1739456.jpg, objectUrl=/article/show_article.do?id=584521830347, replyNumber=0, likeNumber=170, createdTime=2022-03-20, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=584521830347, moduleTitle=Thorax：吸烟对特发性肺纤维化发展的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=584521830347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1204279, encodeId=98c312042e921, content=<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, objectTitle=特发性肺纤维化患者肺康复与生存期相关, objectType=article, longId=220032, objectId=e87e220032bd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021119/1636437425354_5589937.jpg, objectUrl=/article/show_article.do?id=e87e220032bd, replyNumber=0, likeNumber=185, createdTime=2022-03-20, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e87e220032bd, moduleTitle=特发性肺纤维化患者肺康复与生存期相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e87e220032bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1051030, encodeId=3469105103094, content=<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>这个综述全面, objectTitle=综述：特发性肺纤维化治疗药物治疗进展, objectType=article, longId=216060, objectId=d14f21606025, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20210819/432253f6fe8b4ccf8ed27604419d1b28.jpg, objectUrl=/article/show_article.do?id=d14f21606025, replyNumber=0, likeNumber=0, createdTime=2021-09-14, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d14f21606025, moduleTitle=综述：特发性肺纤维化治疗药物治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d14f21606025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=971274, encodeId=82279e1274ab, content=学习<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, objectTitle=中国特发性肺纤维化临床－影像－病理诊断规范, objectType=guider, longId=8245, objectId=ad61f1c00156062b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=ad61f1c00156062b, replyNumber=0, likeNumber=199, createdTime=2021-06-06, rootId=0, userName=14775a26m11暂无昵称, userId=c7ad5218670, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad61f1c00156062b, moduleTitle=中国特发性肺纤维化临床－影像－病理诊断规范, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=ad61f1c00156062b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=971273, encodeId=c08c9e1273d9, content=<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>学习, objectTitle=2021 德国S2K指南：特发性肺纤维化的诊断, objectType=guider, longId=13544, objectId=70a971c002090528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=70a971c002090528, replyNumber=0, likeNumber=212, createdTime=2021-06-06, rootId=0, userName=14775a26m11暂无昵称, userId=c7ad5218670, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70a971c002090528, moduleTitle=2021 德国S2K指南：特发性肺纤维化的诊断, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=70a971c002090528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=907037, encodeId=daa390e03745, content=对于中重度特发性肺纤维化，甲氧苄啶与磺胺甲恶唑联合治疗不能降低患者死亡、肺移植或急诊住院综合风险。<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, objectTitle=JAMA：甲氧苄啶-磺胺甲恶唑对中重度特发性肺纤维化患者不良预后的作用, objectType=article, longId=204394, objectId=d4eb20439424, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201210/1607599416457_2051781.jpg, objectUrl=/article/show_article.do?id=d4eb20439424, replyNumber=0, likeNumber=245, createdTime=2020-12-11, rootId=0, userName=Psycho.Dr Du, userId=a8fb2299762, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4eb20439424, moduleTitle=JAMA：甲氧苄啶-磺胺甲恶唑对中重度特发性肺纤维化患者不良预后的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4eb20439424)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803343, encodeId=6cb580334363, content=<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, objectTitle=Thorax：特发性肺纤维化的职业和环境危险因素, objectType=article, longId=197766, objectId=a5c719e766dd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020719/1595144259658_1739456.jpg, objectUrl=/article/show_article.do?id=a5c719e766dd, replyNumber=0, likeNumber=255, createdTime=2020-07-19, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5c719e766dd, moduleTitle=Thorax：特发性肺纤维化的职业和环境危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5c719e766dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肺纤维化

2020-05-29发表于威斯康星

showtest (审核中...)

前往app查看评论内容

#黄芪#是一种很有前途的#抗纤维化#药物，最好还要配合#活血#的药物，或溶栓类药物、化痰类药物一起治疗，应该有一定的潜力，对#肺纤维化#，#肾纤维化#，#肝纤维化#等。

黄芪及其配方作为纤维化疾病的治疗选择

2023-02-07发表于上海

ms6000000798514104 (审核中...)

前往app查看评论内容

#肺纤维化#吡非尼酮尼达尼布

综述：特发性肺纤维化治疗药物治疗进展

2022-10-28

医者仁者 (审核中...)

前往app查看评论内容

#肺纤维化#

Thorax：吸烟对特发性肺纤维化发展的影响

2022-03-20

医者仁者 (审核中...)

前往app查看评论内容

#肺纤维化#

特发性肺纤维化患者肺康复与生存期相关

2022-03-20

病毒猎手 (审核中...)

前往app查看评论内容

#肺纤维化#这个综述全面

综述：特发性肺纤维化治疗药物治疗进展

2021-09-14

14775a26m11暂无昵称 (审核中...)

前往app查看评论内容

学习#肺纤维化#

中国特发性肺纤维化临床－影像－病理诊断规范

2021-06-06

14775a26m11暂无昵称 (审核中...)

前往app查看评论内容

#肺纤维化#学习

2021 德国S2K指南：特发性肺纤维化的诊断

2021-06-06

Psycho.Dr Du (审核中...)

前往app查看评论内容

对于中重度特发性肺纤维化，甲氧苄啶与磺胺甲恶唑联合治疗不能降低患者死亡、肺移植或急诊住院综合风险。#肺纤维化#

JAMA：甲氧苄啶-磺胺甲恶唑对中重度特发性肺纤维化患者不良预后的作用

2020-12-11

lovetcm (审核中...)

前往app查看评论内容

#肺纤维化#

Thorax：特发性肺纤维化的职业和环境危险因素

2020-07-19

科室
- - 订阅+
  - 更多科室
工具
服务